Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of duloxetine in children and adolescents with depressive disorder
jRCT2080223678Phase 3Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of duloxetine in major depressive disorder (MDD) and persistent depressive disorder (PDD), sponsored by Shionogi & Co., Ltd. Started Oct 2017; status: completed.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)persistent depressive disorder (PDD)
Beyond the preview
Go deeper on jRCT2080223678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223678.